Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
Anne Clavreul,1,2 Milad Pourbaghi-Masouleh,2,3 Emilie Roger,4 Philippe Menei1,2 1Department of Neurosurgery, CHU, Angers, France; 2CRCINA, INSERM, University of Nantes, University of Angers, Angers, France; 3Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University o...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0a2d800fa252474da15c67fff80cae46 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!